(Q43882657)

English

Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time

scientific article published on 30 July 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: analysis of trends over time (English)

1 reference

Europe PubMed Central

27 November 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Emil Scosyrev

1

1 reference

Europe PubMed Central

27 November 2017

Guan Wu

2

1 reference

Europe PubMed Central

27 November 2017

Supriya Mohile

3

1 reference

Europe PubMed Central

27 November 2017

Edward M Messing

4

1 reference

Europe PubMed Central

27 November 2017

language of work or name

0 references

publication date

30 July 2012

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

118

1 reference

Europe PubMed Central

27 November 2017

23

1 reference

Europe PubMed Central

27 November 2017

5768-5776

1 reference

Europe PubMed Central

27 November 2017

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Screening with prostate specific antigen and metastatic prostate cancer risk: a population based case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Prostate cancer screening and mortality: a case-control study (United States).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality: a case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Prostate-specific antigen screening and mortality from prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

The effectiveness of screening for prostate cancer: a nested case-control study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Randomised prostate cancer screening trial: 20 year follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Screening decreases prostate cancer mortality: 11-year follow-up of the 1988 Quebec prospective randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Mortality results from a randomized prostate-cancer screening trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Comorbidity and mortality results from a randomized prostate cancer screening trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Systematic review of early vs deferred hormonal treatment of locally advanced prostate cancer: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27503

21 January 2018

Identifiers

10.1002/CNCR.27503

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43882657&oldid=2111342231"